These agents have demonstrated the ability to modulate carbohydrate metabolism by reducing fasting and post-meal hyperglycemia, enhancing tissue insulin sensitivity, and supporting pancreatic β-cell function. This evidence concerns the gene INS and Hyperglycemia.